-- NovoCure (NVCR) shares were up more than 24% in Thursday trading after the company posted its Q1 financial results.
The pharmaceutical company reported early Thursday a Q1 net loss of $0.62 per diluted share, widening from a loss of $0.31 a year earlier.
Analysts polled by FactSet expected a loss of $0.51.
Net revenue for the quarter ended March 31 was $174.1 million, up from $155 million a year earlier.
Analysts surveyed by FactSet expected $167.8 million.
The company said it now expects 2026 total net revenue of $690 million to $710 million, compared with its prior guidance of between $675 million and $705 million. Analysts polled by FactSet expect $694.7 million.
Price: $14.81, Change: $+2.88, Percent Change: +24.14%